The Senate Report on Clinical Trials – A Tentative Step Forward

There needs to be more transparency in clinical drug trials including the value of the drugs from the viewpoint of patient benefit, reasons for terminating early, outsourcing to developing countries and a focus on efficacy rather than economics.

Read Article →